{"product_id":"payer-perspectives-on-digital-health","title":"Payer Perspectives on Digital Health","description":"\u003cp\u003ePayer Perspectives on Digital Health\u003c\/p\u003e \n\n\u003cp\u003eHow do payers assess the value of digital health technology to them? For payers, their interest lies in digital health tools that contribute to better patient outcomes and lower health costs by unlocking evidence of value and cost efficiency. So how do payers rate current digital health offerings? Which technologies do they value and why? What are the barriers which must be overcome and what is pharma’s role? In this report US and European payers assess the technologies that are driving digital health and impacting payer policies and practice.\u003c\/p\u003e\n\n\u003cp\u003eCompanies\u003c\/p\u003e\n\n\u003cp\u003eBabylon, Welldoc, Dario, Pear Therapeutics, Akili, Big Health, Kaia, Orexo, Voluntis, Freespira, Omron Healthcare, Swing Therapeutics\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"November, 2022 \/ - \/ MCW16238973","offer_id":47654083297586,"sku":null,"price":7140.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/payer-perspectives-on-digital-health","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}